Provided by Tiger Trade Technology Pte. Ltd.

COMPASS Pathways plc

13.33
-0.4900-3.55%
Post-market: 13.430.1000+0.75%19:59 EDT
Volume:2.08M
Turnover:28.33M
Market Cap:1.84B
PE:-3.69
High:14.02
Open:13.82
Low:13.30
Close:13.82
52wk High:15.40
52wk Low:4.29
Shares:138.00M
Float Shares:107.00M
Volume Ratio:0.92
T/O Rate:1.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6118
EPS(LYR):-3.0800
ROE:-319.07%
ROA:-29.08%
PB:21.76
PE(LYR):-4.33

Loading ...

Compass Pathways (CMPS) Earnings Call Highlights COMP360’s Path

TIPRANKS
·
Aug 21

How COMPASS Pathways’ VA Psilocybin Trial (CMPS) Has Reframed Its Veteran Mental Health Ambitions

Simply Wall St.
·
Aug 20

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS Pathways (CMPS)

TIPRANKS
·
Aug 13

COMPASS Pathways (CMPS) Gets a Buy from Evercore ISI

TIPRANKS
·
Aug 10

Analysts’ Top Healthcare Picks: COMPASS Pathways (CMPS), Trulieve Cannabis (TRLV)

TIPRANKS
·
Aug 08

Compass Pathways is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Aug 07

Compass Pathways price target raised to $22 from $17 at B. Riley

TIPRANKS
·
Aug 06

RBC Adjusts PT on COMPASS Pathways to $21 From $22, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 06

Ireland's GH Research Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 06

Scholar Rock Q2 Net Loss Narrows

Reuters
·
Aug 06

Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin

THOMSON REUTERS
·
Aug 06

Compass Pathways Grants New-Hire Inducement Equity Awards at USD 11.25 Per Share

Reuters
·
Aug 06

Compass Pathways Announces New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 06

Compass Pathways Plc Files for Mixed Shelf Offering; Size not Disclosed - SEC Filing

THOMSON REUTERS
·
Aug 06

Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (CMPS), Geron (GERN) and Azenta (AZTA)

TIPRANKS
·
Aug 06

Compass Pathways PLC Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Compass Pathways Publishes Investor Presentation on Comp360 Psilocybin Program, FDA Filing Progress and Launch Plans

Reuters
·
Aug 05

Earnings Flash (CMPS) Compass Pathways Posts Q2 Loss $1.88 a Share, vs. FactSet Est of $0.33 Loss

MT Newswires Live
·
Aug 05

Compass Pathways' Q2 Loss Widens on Commercial Readiness Activity Costs

Reuters
·
Aug 05

Compass Pathways Q2 EPS $(1.88) Misses $(0.37) Estimate

Benzinga Earnings
·
Aug 05